About Tempo Therapeutics
Tempo Therapeutics is a company based in San Diego (United States) founded in 2014 by Donald Griffin and Westbrook Weaver.. Tempo Therapeutics has raised $20.17 million across 3 funding rounds from investors including Johnson & Johnson Innovation and America’s Seed Fund. Tempo Therapeutics operates in a competitive market with competitors including QBiotics, MediWound, Ilya Pharma, Resolution Therapeutics and ProFibrix, among others.
- Headquarter San Diego, United States
- Founders Donald Griffin, Westbrook Weaver
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20.17 M (USD)
in 3 rounds
-
Latest Funding Round
$16.33 M (USD), Series A
Mar 01, 2024
-
Investors
Johnson & Johnson Innovation
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Tempo Therapeutics
Tempo Therapeutics has successfully raised a total of $20.17M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $16.33 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $16.3M
-
First Round
First Round
(01 Jun 2020)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series A - Tempo Therapeutics | Valuation | Johnson & Johnson Innovation |
|
| Sep, 2020 | Amount | Grant - Tempo Therapeutics | Valuation |
investors |
|
| Jun, 2020 | Amount | Series A - Tempo Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tempo Therapeutics
Tempo Therapeutics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Johnson & Johnson Innovation and America’s Seed Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tempo Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tempo Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tempo Therapeutics Comparisons
Competitors of Tempo Therapeutics
Tempo Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QBiotics, MediWound, Ilya Pharma, Resolution Therapeutics and ProFibrix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecules from plant extracts are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| domain | founded_year | HQ Location |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
|
| domain | founded_year | HQ Location |
Powdered fibrin sealant for surgical bleeding
|
|
| domain | founded_year | HQ Location |
Topical formulations for corneal wounds, ulcers, and scars are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tempo Therapeutics
Frequently Asked Questions about Tempo Therapeutics
When was Tempo Therapeutics founded?
Tempo Therapeutics was founded in 2014 and raised its 1st funding round 6 years after it was founded.
Where is Tempo Therapeutics located?
Tempo Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Tempo Therapeutics?
Westbrook Weaver is the current CEO of Tempo Therapeutics. They have also founded this company.
Is Tempo Therapeutics a funded company?
Tempo Therapeutics is a funded company, having raised a total of $20.17M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3.84M, raised on Jun 01, 2020.
What does Tempo Therapeutics do?
Tempo Therapeutics was founded in 2014 in San Diego, United States. Biomaterials focused on regeneration are developed for wound applications within the biotechnology sector. Microporous Annealed Particle technology is applied to produce synthetic, injectable materials. Immune cells in patients are modulated by these materials to foster biological responses that aid regeneration. Various diseases are addressed through this approach in operations centered on precision engineering.
Who are the top competitors of Tempo Therapeutics?
Tempo Therapeutics's top competitors include Ilya Pharma, QBiotics and Resolution Therapeutics.
Who are Tempo Therapeutics's investors?
Tempo Therapeutics has 2 investors. Key investors include Johnson & Johnson Innovation, and America’s Seed Fund.